We receive funding from a variety of sources that recognize the value of our high-impact research.
Regulatory mechanisms for retinal ganglion cell genesis. Xiuqian Mu (Principal Investigator). National Eye Institute. $2,311,139. 8/1/2023-4/1/2028.
Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Sangita Patel (Co-Investigator). NIH National Eye Institute. $3,944,767. 2/1/2018-1/1/2028.
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). VA Central Office. $330,000. 1/1/2025-12/1/2027.
Injuries of the corneal endothelium. Sangita Patel (Principal Investigator). Department of Veterans Affairs, Biomedical Laboratory Research and Development. $543,160. 10/1/2023-9/1/2027.
“Injuries of the Corneal Endothelium”. Steven Fliesler (Co-Investigator). VA. $543,160. 10/1/2023-9/1/2027.
Optimizing Enhanced Hammerhead Ribozymes for Retinal Nucleic Acid Therapeutics. John Sullivan (Principal Investigator). NIH/NEI Scored 11% (Impact 28) on first submission. $2,239,262. 8/1/2023-3/1/2027.
“Research Career Scientist Award (GS-15)”. Steven Fliesler (Principal Investigator). Dept of Veterans Affairs (VA). $637,073. 10/1/2021-9/1/2026.
Epigenetic Architecture of the RPE and Choroid: Identification of Therapeutic Targets For AMD. Margaret DeAngelis (Principal Investigator). Macular Degeneration Foundation, Inc. $500,000. 5/1/2020-7/1/2025.
ER stress and diabetic retinopathy. Sarah Zhang (Principal Investigator). NIH, NEI. 9/1/2010-2/1/2025.
Molecular Mechanisms of Severe Diabetic Retinopathy. Sarah Zhang (Principal Investigator). NIH. 2/1/2020-1/1/2025.
Ancestry Network for the human cell atlas in the eye. Margaret DeAngelis (Co-Principal Investigator). Chan-Zuckerberg Initiative. $536,859. 2/1/2022-1/1/2025.
Pediatric network for the human cell atlas in the eye. Margaret DeAngelis (Co-Principal Investigator). Chan-Zuckerberg. $517,500. 2/1/2022-1/1/2025.
Deconstructing and modeling the single cell architecture of the age-related macular degeneration retina. Margaret DeAngelis (Co-Principal Investigator). NEI/NIH. $1,822,713. 1/1/1900-1/1/2025.
Molecular Mechanisms of Severe Diabetic Retinopathy. Joshua Jianxin Wang (Co-Investigator). NIH/NEI. 2/1/2020-1/1/2025.
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). Veterans Administration BLRD Merit Award. $715,000. 10/1/2009-12/1/2024.
Development of Enhanced Hammerhead Ribozymes (E-hhRzs) as Therapeutics for AMD and other Retinal Diseases. John Sullivan (Principal Investigator). JB McDonald Foundation, Evergreen CO Donald R. McJunkin, President. $30,000. 1/1/2022-12/1/2024.
Pediatric network for the human cell atlas in the eye (Peds RFA). John Lillvis (Co-Investigator). Chan Zuckerberg Initiative. $400,712. 10/1/2021-9/1/2024.
NIH K08 (EY029007) Sex disparity and estradiol in Fuchs‘ endothelial corneal dystrophy. Sangita Patel (Principal Investigator). NIH. $854,900. 9/1/2018-7/1/2024.
Characterizing Adult Strabismus in the National Veteran's Administration (VA) Health System. John Lillvis (Principal Investigator). Buffalo Translational Consortium. 7/1/2022-6/1/2024.
Clinical Translational Science Award (CTSA). Steven Fliesler (Co-Investigator). National Institutes of Health/NCATS. $22,698,278. 4/1/2019-3/1/2024.